Recent advancements in mass spectrometry (MS) have revolutionized quantitative proteomics, with multiplex isotope labeling emerging as a key strategy for enhancing accuracy, precision, and throughput. This tutorial review offers a comprehensive overview of multiplex isotope labeling techniques, including precursor-based, mass defect-based, reporter ion-based, and hybrid labeling methods. It details their fundamental principles, advantages, and inherent limitations along with strategies to mitigate the limitation of ratio-distortion. This review will also cover the applications and latest progress in these labeling techniques across various domains, including cancer biomarker discovery, neuroproteomics, post-translational modification analysis, cross-linking MS, and single-cell proteomics. This Review aims to provide guidance for researchers on selecting appropriate methods for their specific goals while also highlighting the potential future directions in this rapidly evolving field.
Portable electrochemical analytical devices such as cholesterol sensors are widely used for disease diagnosis. However, these tools are bulky and require bioreceptors for the specific detection of cholesterol. Herein, a novel 3D electrochemical paper-based analytical device (3D-ePAD) combined with a near-field communication (NFC) potentiostat was developed and applied to the nonenzymatic detection of cholesterol. This 3D-ePAD platform was designed so that all working operations are performed on a single device, which is separated into an origami PAD (oPAD) and an inset PAD (iPAD). β-Cyclodextrin (β-CD), which is immobilized on oPAD, is used as a specific material for the nonenzymatic detection of cholesterol. Through this device, cholesterol detection is integrated with a battery-free NFC potentiostat on a smartphone. The concentration of cholesterol was examined through a [Fe(CN)6]3-/4- current signal as a redox indicator, which was previously stored in the detection part of an iPAD. Under optimal conditions, 3D-ePAD/NFC exhibited a linear detection efficiency of 1–500 μM and a maximum detection limit of 0.3 μM for cholesterol detection. Moreover, the proposed sensor was successfully used to measure cholesterol in real serum samples from humans, and the results were consistent with those of a commercial cholesterol meter. Therefore, the new NFC-operated 3D-ePAD platform can be used as an alternative tool for the nonenzymatic quantification of various biomarkers. In addition, 3D-ePAD/NFC can support the diagnosis of other diseases in the future, as the device is inexpensive, portable, and disposable and functions with low sample volumes.
This study investigated the occurrence of ibuprofen, naproxen, sulfamethoxazole, trimethoprim, and efavirenz in water resources (river, estuarine, and sea waters) of the East London coastline, South Africa. These pharmaceuticals were previously reported to be dominant in wastewater and inland rivers of South Africa. Hence, it is important to monitor their occurrence in the coastal and marine environment. The pharmaceuticals of interest were extracted with a solid-phase extraction method and analyzed by using a liquid chromatography-quadrupole time-of-flight mass spectrometry instrument. The analytical method was validated by spiking the environmental samples with a mixture of pharmaceuticals at two concentration levels (5 and 15 μg L–1). The analytical method yielded acceptable recoveries ranging from 75 to 107%, with method quantitation limits from 0.16 to 9.44 ng of L–1. All five targeted pharmaceuticals were detected in seawater samples, with ibuprofen recording the highest concentration of 90 ng L–1. However, it was efavirenz and sulfamethoxazole with the highest concentrations of 572 and 60 ng L–1, respectively, in the Gonubie River that showed high ecotoxicological risks toward the aquatic organisms. There were no risks associated with the occurrence of other targeted pharmaceuticals. The suspect screening showed the occurrence of 57 additional pharmaceuticals in samples, with antibiotics being more dominant. The results of the present study demonstrate a need to perform a more robust investigation on the occurrence of a wide range of pharmaceuticals along the South African coasts.
Synthetic, ecofriendly fuels and chemicals can be produced through Power-To-X (PtX) processes. To study such catalytic processes operando and spatially resolved, magnetic resonance imaging (MRI) is a versatile tool. A main issue in the application of MRI in reactive studies is a lack of knowledge about how the gathered signals can be interpreted into reaction data like temperature or species concentration. In this work, the interaction of methane and gaseous water is studied regarding their longitudinal relaxation time T1 and the chemical shift. To this end, defined quantities of methane-water mixtures were sealed in glass tubes and probed at temperatures between 130 and 360 °C and pressures from 6 to 20 bar. From the obtained T1 relaxation times, the collision cross section of methane with water σj,CH4-H2O is derived, which can be used to estimate the temperature and molar concentration of methane during the methanation reaction. The obtained T1 relaxation times can additionally be used to improve the timing of MRI sequences involving water vapor or methane. Further, details about the measurement workflow and tube preparation are shared.
Electrochemical advanced oxidation (EAO) systems are of significant interest due to their ability to treat a wide range of organic contaminants in water. Boron doped diamond (BDD) electrodes have found considerable use in EAO. Despite their popularity, no laboratory scale method exists to quantify anodic corrosion of BDD electrodes under EAO conditions; all are qualitative using techniques such as scanning electron microscopy, electrochemistry, and spectroscopy. In this work, we present a new method which can be used to quantify average corrosion rates as a function of solution composition, current density, and BDD material properties over relatively short time periods. The method uses white light interferometry (WLI), in conjunction with BDD electrodes integrated into a 3D-printed flow cell, to measure three-dimensional changes in the surface structure due to corrosion over a 72 h period. It is equally applicable to both thin film and thicker, freestanding BDD. A further advantage of WLI is that it lends itself to large area measurements; data are collected herein for 1 cm diameter disk electrodes. Using WLI, corrosion rates as low as 1 nm h–1 can be measured. This enables unequivocal demonstration that organics in the EAO solution are not a prerequisite for BDD anodic corrosion. However, they do increase the corrosion rates. In particular, we quantify that addition of 1 M acetic acid to 0.5 M potassium sulfate results in the average corrosion rate increasing ∼60 times. In the same solution, microcrystalline thin film BDD is also found to corrode ∼twice as fast compared to freestanding polished BDD, attributed to the presence of increased sp2 carbon content. This methodology also represents an important step forward in the prediction of BDD electrode lifetimes for a wide range of EAO applications.
Precision medicine is a new medical approach which considers both population characteristics and individual variability to provide customized healthcare. The transition from traditional reactive medicine to personalized medicine is based on a biomarker-driven process and a deep knowledge of biological mechanisms according to which the development of diseases occurs. In this context, the advancements in high-throughput omics technologies represent a unique opportunity to discover novel biomarkers and to provide an unbiased picture of the biological system. One of the medical fields in which omics science has started to be recently applied is that of ophthalmology. Ocular diseases are very common, and some of them could be highly disabling, thus leading to vision loss and blindness. The pathogenic mechanism of most ocular diseases may be dependent on various genetic and environmental factors, whose effect has not been yet completely understood. In this context, large-scale omics approaches are fundamental to have a comprehensive evaluation of the whole system and represent an essential tool for the development of novel therapies. This Review summarizes the recent advancements in omics science applied to ophthalmology in the last ten years, in particular by focusing on proteomics, metabolomics and lipidomics applications from an analytical perspective. The role of high-efficiency separation techniques coupled to (high-resolution) mass spectrometry ((HR)MS) is also discussed, as well as the impact of sampling, sample preparation and data analysis as integrating parts of the analytical workflow.